Anavex Life Sciences Corp (AVXL)

[Amatuer17]

I agree with your argument.

See the definition of PM below. Is AVXL actually following any of those characteristics? A strong NO

1. They have not identified biomarkers that will differentiate patients
2. They have not used any characteristics in patients to develop patient specific medicine or dosing
3. They have not even designed the trial to select patients based on individual characteristics or biomarkers
4. The drug is being developed as a single dose for each and every patient.

So where is the precision part of drug development and trial. It is in M’s mind and in all his decks.

The definition of precision medicine is
“ precision medicine is "an emerging approach for disease treatment and prevention that takes into account individual variability in genes, environment, and lifestyle for each person." This approach will allow doctors and researchers to predict more accurately which treatment and prevention strategies for a particular disease will work in which groups of people.
It is in contrast to a one-size-fits-all approach, in which disease treatment and prevention strategies are developed for the average person, with less consideration for the differences between individuals.”